Skip to content
Indigenous, Medical Health Aged Care

Nurses & Midwives supporting ‘Yes’ vote for a Voice to Parliament

The Australian Nursing and Midwifery Federation (ANMF) 2 mins read

This National Reconciliation Week (27 May - 3 June), the country’s largest union, the Australian Nursing and Midwifery Federation (ANMF), is giving its unequivocal support to a ‘Yes’ vote for an enshrined Voice to Parliament.

 

The ANMF’s members in nursing, midwifery and aged care understand that racism is a serious health issue, which can negatively impact on both mental and physical health outcomes in Aboriginal and Torres Strait Islander communities.

 

“As frontline health professions working across Australia, we believe Constitutional recognition and a Voice to Parliament will be important mechanisms to address racism and in turn, help close the gap in health outcomes between Aboriginal and Torres Strait Islander peoples and non-Indigenous Australians,” ANMF Federal Secretary Annie Butler said today.

 

“Voting ‘Yes’ will ensure that Aboriginal and Torres Strait Islander peoples are rightfully acknowledged as Australia’s first people in our Constitution and through a Voice to Parliament, they can have a meaningful say on issues like health, which affect their communities the most.

 

“It’s why a ‘Yes’ vote will be an important step along the path to Reconciliation, helping to address the interpersonal and systemic racism that still exists in Australian society.”

 

The ANMF is a proud supporter of the Unions for Yes campaign and acknowledges the hard work of Aboriginal and Torres Strait Islander people to bring the Voice proposal to Referendum.

 

Unions for Yes

 

We encourage Australians to learn about what is proposed in this Referendum and to reflect upon the impacts of racism in our society. 

 

 

  


About us:

 

The ANMF, with over 321,000 members, is the industrial and professional voice for nurses, midwives and carers in Australia.

ANMF media release authorised by Annie Butler, ANMF Federal Secretary. 1/365 Queen St, Melbourne. 


Contact details:

ANMF media inquiries:

Richard Lenarduzzi 0411 254 390

More from this category

  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

  • Medical Health Aged Care, Science
  • 13/09/2024
  • 11:08
La Trobe University

Centre to play key role in global AI medical research

Artificial intelligence promises to unlock new cures for cancer and other diseases by revolutionising the speed, cost and availability of personally designed drugs and enabling these to be tested on “digital twins" before being given to patients. AI will enable broad-spectrum like chemotherapy to be replaced by these more personalised, better targeted treatments. Scientists at La Trobe University's new Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI), launched today, will also apply AI techniques to mRNA therapy development to enable faster design of more precise and effective treatments. Vice-Chancellor Professor Theo Farrell said ACAMI would sit within La Trobe’s…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.